ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BXP Beximco Pharma

40.50
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Beximco Pharma LSE:BXP London Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 40.50 39.00 42.00 41.40 40.50 40.50 30,494 08:00:25

Beximco Pharma Discussion Threads

Showing 1676 to 1696 of 2150 messages
Chat Pages: Latest  74  73  72  71  70  69  68  67  66  65  64  63  Older
DateSubjectAuthorDiscuss
28/8/2020
16:17
Thanks Greg.
davebowler
28/8/2020
16:11
Dhaka open on Sunday so maybe more fuel to the share price for a BIG monday rise.

As previously mentioned, UK press coverage also a major factor.

GLA

greg the grinch
28/8/2020
16:07
Deal with AZN should hopefully allay 'dodgy' company fears, and ER has been reasonably stable.

I do know shares are not fungible so no arbitrage opportunities.

Still too much of a discount - hopefully this deal can help.

greg the grinch
28/8/2020
15:49
The price difference is more likely due to the view from the UK of less regulatory and financial oversight of companies in countries like Bangladesh. There is also the issue of exchange rate fluctuations.
cb7
28/8/2020
15:37
osc.c

So BXP cant buy the AIM BXP shares? - hence the price difference?

TIA

greg the grinch
28/8/2020
14:14
Bought some today. Rarely buy at highs but know this company from years ago and fair chance of media attention at weekend. Great announcement and having AZ onside is significant. SNG and AVCT multibagged overnight on similar type news, this hasn't and could be delayed action gain
microscope
28/8/2020
13:40
The usual discount difference between the UK ADRs price and the Dhaka shares price is because the Bangladeshi Govt. have mandated that the Company cannot buy back in it's ADRs.
And because it's an ADR in the UK, rather than an ordinary share, all share news outlets don't carry it's news, so it's completely under the radar. e,g. look for this today on the "news headlines" page of ADVFN. It's not there.
The one HUGE takeaway from today's news is that 2 potential eventual buyers for the Company have been flagged up in AZN and SII.
And, of course, any offer in Dhaka translates equally to the UK, so any takeover gives us 30%-40% more upside than Dhaka shareholders.
In the meantime, although debt is moderately high, they still pay a good divvy.

outsizeclothes.com
28/8/2020
11:59
I'm off to sit and wait, see you in a while.
greg the grinch
28/8/2020
11:58
Hmm... makes me wonder if the differential is caused by a large holder mistakenly tracking the wrong share? Possibly set to auto-track with the wrong settings?
greg the grinch
28/8/2020
11:55
You need to look at beximco pharma NOT beximco. which was the original parent company.

This is the correct one



This is NOT the correct one



GLA

£ to Taka approx 1 : 1.12

greg the grinch
28/8/2020
11:49
Well summarised PharmaGiles. I’ve been here since the 30s and 40s. I think it is a really key point to note that Dhaka is closed today. All eyes on movement next week.
toadhall1
28/8/2020
11:38
It's currently 95p equivalent on the Dhaka Stock Exchange (DSE) - but the DSE is closed on Friday's (hence no lift today). The GDRs (on AIM) are = to the ordinary shares on the DSE but to-date we haven't seen parity between the DSE and AIM SPs. They're also selling Remdesivir into 10 countries - through the Bangladesh government, and reportedly were making 160,000 vials this month, with plans to significantly scale up production. They pretty much make all the COVID drugs, and also big in inhalers - which could be relevant as Remdesivir is exploring the inhaler route (as are companies like Synairgen).. Dividends are paid out annually, to those on the books in Nov, and this year the rules are they should pay out 30% of profits to shareholders. Profits are likely to have increased over last years, but potentially growth may not be double digit for the first time for a while, due to a potential/temporary dip in Q4 (April - June) - which looks set to recover in Q1 (July - Sept). The generics market is relatively low risk - as long as you're competing on price (which they can). Been here for a while so nice to see the rise - although I still think undervalued.
pharma giles
28/8/2020
11:11
Yes -I wonder if there has been dilution -its price is 26.2 in Dhaka but 65p in BDT is 73 BDT!!
hxxps://www.xe.com/currencyconverter/convert/?Amount=0.60&From=GBP&To=BDT

davebowler
28/8/2020
10:59
Can anyone explain how the AIM share price and the Dhaka share price relate. Or do they not at all?
fegger
28/8/2020
10:46
Hmmm... interesting to see if this leads to more deals with AZN.... or AZN buy them out?

GLA

greg the grinch
28/8/2020
10:41
Here is another Dhaka price graph - different time scale.
greg the grinch
28/8/2020
10:39
I am waiting for the buyout - that way the AIM share price reduction (for some unknown reason always lower than Dhaka) will disappear.

I guess £2, if and when it happens.

This deal will do a lot for the image of BXP and hopefully help erase the price differential.

I think med/long term the price will keep chugging up.

GLA

greg the grinch
28/8/2020
09:34
Well done all who held on!
zcaprd7
28/8/2020
09:31
the wait from April 2017 from which point the share price was on a downward trend has been for the patient.

hopefully that patience will now be rewarded.

mfhmfh
28/8/2020
09:23
Great news but dont know anything about this co.Are they well financed. No numbers mentioned today but seems exciting just the same!!!
billthebank
28/8/2020
09:07
Wouldnt be surprised to see this multibag today. Impossible to buy and huge news given the Astrazenca tie in.
genierub
Chat Pages: Latest  74  73  72  71  70  69  68  67  66  65  64  63  Older